Chapter 1289

Pharmaceutical companies are the most willing to pay in the world.

From the top to the bottom, from Pfizer to the Bela pharmaceutical factory in Mozambique, one can count as one. The expenditure on publicity and marketing, government public relations and legal security is in the forefront of all industries.

In short, the more profitable and disreputable an enterprise is, the more it needs to spend a lot of extra money to maintain its collapsed image and protect its fragile ecological chain, such as arms dealers, energy companies or pharmaceutical companies.

On the other hand, the larger the scale of a company, the more transnational and trans regional it is, the more resources it needs to invest in it.

Why is Coca Cola willing to pay tens of thousands of dollars to Yang Rui to make an investment that is not in their plan? Because in their marketing plan, it's very common to spend tens of thousands of dollars on a meeting and a project. Even Coca Cola in China is willing to spend a lot of cash when it finds a suitable project.

Sometimes, such a multinational company will pay tens of thousands of dollars to an unknown scholar in exchange for his "outspoken speech", or simply a speech to people who don't care. The round-trip first-class air tickets and hotel expenses, plus lecture expenses, are amazing enough.

Pharmaceutical companies are even more ambitious.

When a company has to spend tens of millions of dollars for various lawsuits every year on average, they are more generous in maintaining relationships than the annual output value of an ordinary factory.

Sometimes, for the sake of a new drug lobby, pharmaceutical companies can pull hundreds of millions of dollars out of their pockets.

Astra is also one of several original pharmaceutical companies in the world. It pays countless taxes to the Swedish government every year, and its annual turnover is tens of billions of yuan.

For pharmaceutical companies at this level, their first concern is the research and development of drugs and the marketing of new drugs.

In fact, compared with small pharmaceutical companies, the R & D capability of large pharmaceutical companies is not necessarily stronger. Their most used way is still to buy patents from small pharmaceutical companies and use their strong marketing ability and government relations to promote drugs.

However, drug patent is only a link of drug research and development.

At the level of Astra, they have to care not only about what new drugs are coming out, but also about what new drugs we can make now.

What new drugs can be made depends on the development and initiative of basic medicine.

For example, G-protein coupled receptor is the source of new drugs for a long time in the future. At one time, 50% of new drugs were developed in G-protein coupled receptor.

Astra naturally is not reconciled to the person, for Yang Rui handed over the olive branch, they a to grasp.

Companies like large pharmaceutical companies are not afraid of your offer, especially those in Sweden.

Yang Rui is not the first biologist interested in the Nobel Prize, nor will he be the last.

After a simple visit to the pharmaceutical factory on that day, the Astra official in charge of the itinerary and introduction came over and said, "Mr. Yang Rui, I heard that your Chinese embassy is going to hold a dinner party. I've signed up. "

"Oh, thank you for your participation." Yang Rui showed considerable enthusiasm.

"Let me introduce myself again, Pulitzer. I'm from Stockholm. When I was a child, my favorite festival every year was the Nobel Prize ceremony. " Pulitzer said with a smile: "at that time, Stockholm was the most lively place. We drank, laughed and watched real scientists win prizes together."

Yang Rui nodded slightly.

"There is a saying that even the most active Swedes are not as outgoing as the most shy Americans, except after drinking." Pulitzer raised the glass he held in his hand and said, "Mr. Yang Rui, Astra believes that your research on G protein coupled receptor and PCR has praiseworthy originality and influence, and you deserve the Nobel Prize."

"Is that what Astra thinks?"

"Of course."

"Thank you very much for your appreciation." Yang Rui couldn't help looking up. That's why he came to Sweden. He has to tell people that there is someone here who is qualified to win the Nobel Prize, and that person is willing to win the Nobel Prize.

However, Astra is the most easily conquered Swedish company. Their relationship with Jericho and their lack of integrity as a pharmaceutical company determine that they are more willing to support Yang Rui. However, from the perspective of stepping stone, Astra's significance is extraordinary.

Yang Rui also kindly said: "the attitude of Astra company is very important to me. Mr. Pulitzer, you are the first company I contacted in Sweden and the first company that gave me full support. Thank you very much."Pulitzer laughed very quickly and said, "Mr. Yang Rui, I want to make it clear that it can not be called the full support of Astra. Of course, we support you very much..."

"Under what conditions will you give your full support?" In the face of such multinational companies, even Swedish multinational companies, Yang Rui does not need to maintain the so-called celebrity style.

Commercial companies are companies that pay attention to trading, and Yang Rui is also a person with capital.

Pulitzer gave Yang Rui a rather unexpected look and said, "what you've done reminds me of the Americans. Oh, no, they should be more like the British."

"Oh?"

"The British always discuss some very important issues in a flat tone."

"So 007 in England is very famous." "I think Swedes are always very calm," Yang said with a smile

"It's more apathy." Pulitzer changed the subject and said, "Mr. Yang Rui, if Astra supports you fully, what kind of reward can you offer?"

"I can give your researchers a month's lecture and answer their questions." Yang ruidao.

Pulitzer was stunned for a moment. He couldn't help laughing and said, "Mr. Yang Rui, you are a good joker."

"It's not a joke, Mr. Pulitzer."

Pulitzer said: "Mr. Yang Rui, I prefer to think it's a joke. Astra is a large pharmaceutical company with many years of tradition and self-confidence. We are willing to accept information from the outside world and discuss with researchers from other countries, but..."

"It took me only two months to make deferonone." Yang Rui did not let him finish, interrupted: "and made seven active substances, now it seems that the third phase of clinical is also very smooth, the fourth phase of clinical is no problem..."

Pritzeton was a bit poor at words. Making original new drugs is a big event for any big company. Although Astra is a big company with tens of billions of dollars in marketing, they can pass the original new drugs every year. In fact, no big company can have original new drugs every year. In drug development, cruelty is the norm.

"Think about it." Yang Rui's voice was full of temptation and said: "I am the researcher who knows the G protein coupled receptor best in the world. Although I am a little embarrassed to boast like this, do you think my position is appropriate?"

"Very appropriate, I think." Pulitzer said the words firmly, and the thoughts in his mind were born out in an instant.

G The reason why protein coupled receptor research is called Wangqi is that its seven transmembrane mechanism is so abnormal that it affects almost every aspect of the human body, from smell to life support

In other words, through G protein coupled receptors, it can affect all aspects of the human body, resulting in numerous targets.

And Yang Rui, he is the man holding the king's flag.

Although the news that Yang Rui has completed the second stage of GPCR has not been released, and Pulitzer does not know, no one can copy his progress in the first stage.

In other words, Yang Rui is the first person in G protein coupled receptor.

What's more, he is not a biologist who only knows basic research. He also presided over the development of a new drug.

Such an experience, however, made Pulitzer greedy.

"Full support is a big topic." Pulitzer's expression became more serious, saying: "I don't have the right to decide, but I can report to the CEO."

Sweden is the country that most advocates flat management, and many people are qualified to report to the top.

Yang Rui nodded, laughed again and said, "you don't have to be too nervous. Maybe you can arrange time for me and your researchers to have some in-depth conversations, such as lectures?"

"Would you like that?"

"Of course."

"Great, thank you very much." Pulitzer immediately agreed: "I'll make the corresponding arrangements right away... Oh, do you want to give the lecture a name?"

"How about the G protein coupled receptor experience class." In Yang Rui's mind, what emerges is the image of a salesman who distributes trial clothes.